Table 1.
Clinical Pathology Data of the Subject Involved in This Study
| Characteristic | N=240 | Percent (%) |
|---|---|---|
| Nasopharyngeal Carcinoma | 160 | 33 |
| Non-tumor | 80 | 67 |
| Age | ||
| Median | 47 | |
| Range | 14-68 | |
| Sex | ||
| Male | 106 | 59 |
| Female | 74 | 41 |
| Histology | ||
| WHO I | 0 | 0 |
| WHO II | 24 | 15 |
| WHO III | 49 | 31 |
| WHO IV | 87 | 54 |
| N Lymph Node | ||
| N0 | 10 | 6 |
| N1 | 43 | 27 |
| N2 | 58 | 36 |
| N3 | 49 | 31 |
| T Classification | ||
| T1 | 6 | 4 |
| T2 | 71 | 44 |
| T3 | 37 | 23 |
| T4 | 46 | 29 |
| Clinical Stages | ||
| I | 0 | 0 |
| II | 25 | 16 |
| III | 49 | 31 |
| IV | 86 | 54 |
| Pathology Anatomy | ||
| Undifferentiated | 31 | 19 |
| Non-Keratin, Undif Sub Type | 117 | 73 |
| Non-Keratin, Differentiated | 9 | 6 |
| Keratin | 3 | 2 |
| EBV - EA | ||
| Positive | 132 | 83 |
| Negative | 28 | 18 |
| EBV - EBNA | ||
| Positive | 111 | 69 |
| Negative | 49 | 31 |
| EBV - VCA | ||
| Positive | 145 | 91 |
| Negative | 15 | 9 |